| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892 [J. W., T. O., S. K., M. D., J. Y., D. D., J. M. L.]; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030 [H. Y.]; Free University of Amsterdam, NL-1081-BT the Netherlands [J. L. T. F.]; and Hematology-Oncology Division, Brigham and Women's Hospital, Boston, Massachusetts 02115 [Y. L.]
Fanconi anemia is a rare, inherited disorder characterized by bone marrow failure, congenital malformations, and cancer susceptibility. The group C Fanconi anemia gene, FAC, identified by expression cloning methods, encodes a protein of unknown function that may be involved in the response to apoptotic stimuli. Hematopoietic progenitor cells from Fac knock-out mice are hypersensitive to IFN-
, a molecule that can induce apoptosis through up-regulation of the Fas death receptor. In this study, we used FAC-overexpressing transgenic mice to examine the relationship between FAC and Fas-triggered cell death. Hematopoietic progenitors from FAC-transgenic mice were up to 10-fold less sensitive to the cytolytic effect of Fas-ligation. Our experiments implicate FAC in the regulation of apoptosis mediated by the Fas death receptor.
1 This work was supported in part by NIH Grant HL52138 (to H. Y.) and a Grant from the March of Dimes Birth Defects Foundation (to H. Y.).
2 To whom requests for reprints should be addressed, at NIH, NHLBI, Hematology Branch, 10/ACRF/7C103, Bethesda, MD 20892. Phone: (301) 496-5093; Fax: (301) 496-8396; E-mail: LiuJ@gwgate.nhlbi.nih.gov.
Received 4/21/98. Accepted 6/24/98.
This article has been cited by other articles:
![]() |
J. M. Liu and S. R. Ellis Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood, June 15, 2006; 107(12): 4583 - 4588. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, P. C. Van der Sluis, D. Boulware, L. A. Hazlehurst, and W. S. Dalton The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells Blood, July 15, 2005; 106(2): 698 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Brodeur, I. Goulet, C. S. Tremblay, C. Charbonneau, M.-C. Delisle, C. Godin, C. Huard, E. W. Khandjian, M. Buchwald, G. Levesque, et al. Regulation of the Fanconi Anemia Group C Protein through Proteolytic Modification J. Biol. Chem., February 6, 2004; 279(6): 4713 - 4720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Lensch, M. Tischkowitz, T. A. Christianson, C. A. Reifsteck, S. A. Speckhart, P. M. Jakobs, M. E. O'Dwyer, S. B. Olson, M. M. Le Beau, S. V. Hodgson, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia Blood, July 1, 2003; 102(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Pang, T. A. Christianson, W. Keeble, T. Koretsky, and G. C. Bagby The Anti-apoptotic Function of Hsp70 in the Interferon-inducible Double-stranded RNA-dependent Protein Kinase-mediated Death Signaling Pathway Requires the Fanconi Anemia Protein, FANCC J. Biol. Chem., December 13, 2002; 277(51): 49638 - 49643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bogliolo, O. Cabre, E. Callen, V. Castillo, A. Creus, R. Marcos, and J. Surralles The Fanconi anaemia genome stability and tumour suppressor network Mutagenesis, November 1, 2002; 17(6): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aube, M. Lafrance, C. Charbonneau, I. Goulet, and M. Carreau Hematopoietic Stem Cells from Fancc-/- Mice Have Lower Growth and Differentiation Potential in Response to Growth Factors Stem Cells, September 1, 2002; 20(5): 438 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Pang, T. A. Christianson, W. Keeble, J. Diaz, G. R. Faulkner, C. Reifsteck, S. Olson, and G. C. Bagby The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality Blood, September 1, 2001; 98(5): 1392 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dror and M. H. Freedman Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway Blood, May 15, 2001; 97(10): 3011 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Youssoufian, F. A.E. Kruyt, and X. Li Protein Replacement by Receptor-Mediated Endocytosis Corrects the Sensitivity of Fanconi Anemia Group C Cells to Mitomycin C Blood, January 1, 1999; 93(1): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qiao, A. Moss, and G. M. Kupfer Fanconi Anemia Proteins Localize to Chromatin and the Nuclear Matrix in a DNA Damage- and Cell Cycle-regulated Manner J. Biol. Chem., June 22, 2001; 276(26): 23391 - 23396. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |